Establishment of the Presidential Commission for the Study of Bioethical Issues, 16127 [2010-7232]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 61 / Wednesday, March 31, 2010 / Notices
material on its Web site prior to the
meeting, it will be made publicly
available at the location of the advisory
committee meeting, and the background
material will be posed on ONC’s Web
site after the meeting, at https://
healthit.hhs.gov
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before April 20, 2010. Oral
comments from the public will be
scheduled between approximately 3
p.m. and 3:30 p.m./Eastern Time. Time
allotted for each presentation will be
limited to three minutes each. If the
number of speakers requesting to
comment is greater than can be
reasonably accommodated during the
scheduled open public hearing session,
ONC will take written comments after
the meeting until close of business.
Persons attending ONC’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
ONC welcomes the attendance of the
public at its advisory committee
meetings. Seating is limited at the
location, and ONC will make every
effort to accommodate persons with
physical disabilities or special needs. If
you require special accommodations
due to a disability, please contact Judy
Sparrow at least seven (7) days in
advance of the meeting.
ONC is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://healthit.hhs.gov for procedures
on public conduct during advisory
committee meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act
(Pub. L. 92–463, 5 U.S.C., App. 2).
Dated: March 18, 2010.
Judith Sparrow,
Office of Programs and Coordination, Office
of the National Coordinator for Health
Information Technology.
[FR Doc. 2010–6600 Filed 3–30–10; 8:45 am]
BILLING CODE 4150–45–P
jlentini on DSKJ8SOYB1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Establishment of the Presidential
Commission for the Study of
Bioethical Issues
Office of Public Health and
Science, Office of the Secretary,
Department of Health and Human
Services.
ACTION: Notice.
AGENCY:
VerDate Nov<24>2008
19:40 Mar 30, 2010
Jkt 220001
Authority: Executive Order 13251, dated
November 24, 2009. The Presidential
Commission for the Study of Bioethical
Issues will be governed by provisions of the
Federal Advisory Committee Act, Public Law
92–463, as amended (5 U.S.C. App.), which
sets forth standards for the formation and use
of advisory committees.
SUMMARY: The U.S. Department of
Health and Human Services announces
establishment of the Presidential
Commission for the Study of Bioethical
Issues (the ‘‘Commission’’), as directed
by Executive Order 13521.
FOR FURTHER INFORMATION CONTACT: Ms.
Diane M. Gianelli, Acting Executive
Director, Presidential Commission on
the Study of Bioethical Issues;
Department of Health and Human
Services; and/or Ms. Judith E. Crawford,
Administrative Director, Presidential
Commission on the Study of Bioethical
Issues; Department of Health and
Human Services. Both Ms. Gianelli and
Ms. Crawford work in the Commission’s
office located at: 1425 New York
Avenue, NW., Suite C100; Washington,
DC 20005; Telephone: (202) 233–3960;
Fax: (202) 233–3990.
SUPPLEMENTARY INFORMATION: Under
Executive Order 13521, the President
directed that the Commission shall be
established within the Department of
Health and Human Services (HHS). To
comply with the authorizing directive
and guidelines under the Federal
Advisory Committee Act (FACA), a
charter has been filed with the
Committee Management Secretariat in
the General Services Administration
(GSA), the appropriate committees in
the Senate and U.S. House of
Representatives, and the Library of
Congress to establish the Commission as
a non-discretionary Federal advisory
committee. The charter was filed on
March 10, 2010.
Objectives and Scope of Activities.
The Commission shall advise the
President on bioethical issues that may
emerge as consequences of advances in
biomedicine and related areas of science
and technology. The Commission shall
pursue its work with the goal of
identifying and promoting policies and
practices that ensure scientific research,
healthcare delivery, and technological
innovation are conducted in an ethically
responsible manner. The Commission
shall not be responsible for the review
and approval of specific projects. The
Commission may accept suggestions of
issues for consideration from executive
departments and agencies and the
public as it deems appropriate to
support its mission.
Membership and Designation. The
Commission shall be an expert panel
composed of not more than 13 members,
PO 00000
Frm 00062
Fmt 4703
Sfmt 9990
16127
who will be drawn from fields of
bioethics, science, medicine,
technology, engineering, law,
philosophy, theology, and other areas of
the humanities or social sciences.
Commission members shall be
appointed by the President. The
President shall designate a Chair and
Vice Chair from among the members of
the Commission. At least one, and not
more than three members, may be
bioethicists or scientists drawn from the
executive branch, as designated by the
President; members who are selected
from the Federal sector to fill these
positions on the Commission will be
classified as regular government
employees. The Commission members
who are selected from the public and/
or private sector will be classified as
special government employees.
Administrative Management and
Support. HHS will provide funding and
administrative support for the
Commission to the extent permitted by
law within existing appropriations. Staff
will be assigned to a program office
established to support the activities of
the Commission. Management and
oversight for support services provided
to the Commission will be the
responsibility of the Office of Public
Health and Science, which is a staff
division within HHS Office of the
Secretary. All executive departments
and agencies and all entities within the
Executive Office of the President shall
provide information and assistance to
the Commission as the Chair may
request for purposes of carrying out the
Commission’s functions, to the extent
permitted by law.
The Commission has been established
to replace the President’s Council on
Bioethics. The Council was established
by Executive Order 13237, dated
November 28, 2001. Council operations
were terminated on September 30, 2009.
The authorizing directive for the
Commission, Executive Order 13521,
supersedes Executive Order 13237.
A copy of the Commission charter can
be obtained from the designated
contacts or by accessing the FACA
database that is maintained by the GSA
Committee Management Secretariat. The
Web site for the FACA database is
https://fido.gov/facadatabase/.
Dated: March 25, 2010.
Howard K. Koh,
Assistant Secretary for Health, Office of
Public Health and Science.
[FR Doc. 2010–7232 Filed 3–30–10; 8:45 am]
BILLING CODE 4154–06–P
E:\FR\FM\31MRN1.SGM
31MRN1
]]>Agencies
[Federal Register Volume 75, Number 61 (Wednesday, March 31, 2010)]
[Notices]
[Page 16127]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-7232]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Establishment of the Presidential Commission for the Study of
Bioethical Issues
AGENCY: Office of Public Health and Science, Office of the Secretary,
Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: Executive Order 13251, dated November 24, 2009. The
Presidential Commission for the Study of Bioethical Issues will be
governed by provisions of the Federal Advisory Committee Act, Public
Law 92-463, as amended (5 U.S.C. App.), which sets forth standards
for the formation and use of advisory committees.
SUMMARY: The U.S. Department of Health and Human Services announces
establishment of the Presidential Commission for the Study of
Bioethical Issues (the ``Commission''), as directed by Executive Order
13521.
FOR FURTHER INFORMATION CONTACT: Ms. Diane M. Gianelli, Acting
Executive Director, Presidential Commission on the Study of Bioethical
Issues; Department of Health and Human Services; and/or Ms. Judith E.
Crawford, Administrative Director, Presidential Commission on the Study
of Bioethical Issues; Department of Health and Human Services. Both Ms.
Gianelli and Ms. Crawford work in the Commission's office located at:
1425 New York Avenue, NW., Suite C100; Washington, DC 20005; Telephone:
(202) 233-3960; Fax: (202) 233-3990.
SUPPLEMENTARY INFORMATION: Under Executive Order 13521, the President
directed that the Commission shall be established within the Department
of Health and Human Services (HHS). To comply with the authorizing
directive and guidelines under the Federal Advisory Committee Act
(FACA), a charter has been filed with the Committee Management
Secretariat in the General Services Administration (GSA), the
appropriate committees in the Senate and U.S. House of Representatives,
and the Library of Congress to establish the Commission as a non-
discretionary Federal advisory committee. The charter was filed on
March 10, 2010.
Objectives and Scope of Activities. The Commission shall advise the
President on bioethical issues that may emerge as consequences of
advances in biomedicine and related areas of science and technology.
The Commission shall pursue its work with the goal of identifying and
promoting policies and practices that ensure scientific research,
healthcare delivery, and technological innovation are conducted in an
ethically responsible manner. The Commission shall not be responsible
for the review and approval of specific projects. The Commission may
accept suggestions of issues for consideration from executive
departments and agencies and the public as it deems appropriate to
support its mission.
Membership and Designation. The Commission shall be an expert panel
composed of not more than 13 members, who will be drawn from fields of
bioethics, science, medicine, technology, engineering, law, philosophy,
theology, and other areas of the humanities or social sciences.
Commission members shall be appointed by the President. The President
shall designate a Chair and Vice Chair from among the members of the
Commission. At least one, and not more than three members, may be
bioethicists or scientists drawn from the executive branch, as
designated by the President; members who are selected from the Federal
sector to fill these positions on the Commission will be classified as
regular government employees. The Commission members who are selected
from the public and/or private sector will be classified as special
government employees.
Administrative Management and Support. HHS will provide funding and
administrative support for the Commission to the extent permitted by
law within existing appropriations. Staff will be assigned to a program
office established to support the activities of the Commission.
Management and oversight for support services provided to the
Commission will be the responsibility of the Office of Public Health
and Science, which is a staff division within HHS Office of the
Secretary. All executive departments and agencies and all entities
within the Executive Office of the President shall provide information
and assistance to the Commission as the Chair may request for purposes
of carrying out the Commission's functions, to the extent permitted by
law.
The Commission has been established to replace the President's
Council on Bioethics. The Council was established by Executive Order
13237, dated November 28, 2001. Council operations were terminated on
September 30, 2009. The authorizing directive for the Commission,
Executive Order 13521, supersedes Executive Order 13237.
A copy of the Commission charter can be obtained from the
designated contacts or by accessing the FACA database that is
maintained by the GSA Committee Management Secretariat. The Web site
for the FACA database is https://fido.gov/facadatabase/.
Dated: March 25, 2010.
Howard K. Koh,
Assistant Secretary for Health, Office of Public Health and Science.
[FR Doc. 2010-7232 Filed 3-30-10; 8:45 am]
BILLING CODE 4154-06-P
